Aktivitas Anti Trombotik dari Genus Curcuma : Kajian Sistematik

Fajar Jamaluddin Sandhori, Idha Kusumawati, Samirah Samirah, Subhan Rullyansyah, Firmansyah Ardian Ramadhani, Hanif Rifqi Prasetyawan, Mega Ferdina Warsito

Abstract


Background : The Curcuma genus has various pharmacological activities, one of these is antithrombotic activity by preventing thrombus formation. Some of its chemical contents are also known to inhibit thrombus formation including curcumin, bisdemethoxycurcumin, ar-turmerone, and xanthorrizhol compounds. Antithrombotic drugs are used for the prevention and treatment of thrombosis whose mechanisms are divided into anticoagulants, thrombolytics, and antiplatelets. Objective: This review article discusses the potential of Curcuma genus as antithrombotic, including anticoagulant, antiplatelet, and thrombolytic, Methods: This study was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method using four databases : PubMed, ScienceDirect, Scopus, and Google Scholar from July to December 2023. The inclusion criteria used were articles on antithrombotic activity, including anticoagulants, antiplatelets, and thrombolytics from the genus Curcuma. Results: The number of articles obtained from four databases was 3413 articles. Furthermore, based on the results of filtering duplicate articles from all databases, 2771 articles were selected and then continued with screening based on inclusion and exclusion criteria until 15 articles were selected as material for systematic review. Conclusion: Curcuma species that have potential as antithrombotic are Curcuma longa, Curcuma zedoaria Rosc., Curcuma amada, Curcuma caesia, Curcuma aeruginosa, Curcuma latifolia, Curcuma aromatica Salisb, Curcuma wenyujin, and Curcuma xanthorrhiza

Full Text:

PDF

References


  1. Gustiara R, Jaya H, Santoso I. Sistem Pakar Mendiagnosa Penyakit Trombosis Vena Dalam Menggunakan Metode Case Based Reasoning. Jurnal Sistem Informasi Triguna Dharma (JURSI TGD). 2022;1(4):498.
  2. Gao L, Wang F, Chen Y, Li F, Han B, Liu D. The antithrombotic activity of natural and synthetic coumarins. Fitoterapia. 2021;154(August):104947.
  3. Ramdasari Aksan S, Na S, Banne Tondok S, Kemal Firdaus E, Studi Magister Keperawatan P, Kedokteran F, et al. Asupan Tinggi Garam Sebagai Perilaku Berisiko Terhadap Penyakit Kardiovaskular: Literature Review High Salt Intake as Risk Behavior Toward Cardiovascular Disease: A Literature Review. Vol. 4, Jurnal Keperawatan Klinis dan Komunitas. 2020.
  4. Chen C, Yang FQ, Zhang Q, Wang FQ, Hu YJ, Xia ZN. Natural products for antithrombosis. Evidence-based Complementary and Alternative Medicine. 2015;2015.
  5. Fintel DJ. Oral antiplatelet therapy for atherothrombotic disease: Overview of current and emerging treatment options. Vasc Health Risk Manag. 2012;8(1):77–89.
  6. Feher G. Clinical importance of aspirin and clopidogrel resistance. World J Cardiol. 2010;2(7):171.
  7. Baigent C, Sudlow C, Collins R, Peto R. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J. 2002;324(7329):71–86.
  8. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet. 2006;367(9510):606–17.
  9. Elhawary EA, Moussa AY, Singab ANB. Genus Curcuma: chemical and ethnopharmacological role in aging process. Vol. 24, BMC Complementary Medicine and Therapies. BioMed Central Ltd; 2024.
  10. Sun W, Wang S, Zhao W, Wu C, Guo S, Gao H, et al. Chemical constituents and biological research on plants in the genus Curcuma. Crit Rev Food Sci Nutr. 2017;57(7):1451–523.
  11. Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012;45(4):221–6.
  12. Lee HS. Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone. Bioresour Technol. 2006;97(12):1372–6.
  13. Jantan I, Saputri FC, Qaisar MN, Buang F. Correlation between chemical composition of curcuma domestica and curcuma xanthorrhiza and their antioxidant effect on human low-density lipoprotein oxidation. Evidence-based Complementary and Alternative Medicine. 2012;2012(Ldl).
  14. Subramani B, Sathiyarajeswaran P. Current update on herbal sources of antithrombotic activity—a comprehensive review. Egypt J Intern Med. 2022;34(1).
  15. Xia Q, Wang X, Xu DJ, Chen XH, Chen FH. Inhibition of platelet aggregation by curdione from Curcuma wenyujin essential Oil. Thromb Res. 2012;130(3):409–14.
  16. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. International Journal of Surgery. 2021;88(March).
  17. Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015 Sep 1;13(3):132–40.
  18. Chan NC, Weitz JI. Antithrombotic agents new directions in antithrombotic therapy. Circ Res. 2019;124(3):426–36.
  19. Jin NZ, Gopinath SCB. Potential blood clotting factors and anticoagulants. Biomedicine and Pharmacotherapy. 2016;84:356–65.
  20. Ashish DK, Goel R, Bansal P, , Shikha Sharma UG Scholar, KIET School of Pharmacy G. Standardization and Thrombolytic activity of Curcuma longa & Withania somnifera. 2018;32–48.
  21. Dinesh Y, Abilasha R, Ramani P, Rajeshkumar S. Assessment of Cytotoxic, Antioxidant, Thrombolytic, Anti Inflammatory and Antimicrobial Activity of Curcuma longa Linn, Cissus quadrangularis and Boerhaavia diffusa Herbal Mixture - An In vitro Study. J Pharm Res Int. 2021;33:1766–77.
  22. Jain S, Dangi CBS, Kaur M, Singh H, Peter J. Plant as anticogulant/antithrombotic agent. 2014;(March).
  23. Ngo T, Kim K, Bian Y, An GJ, Bae ON, Lim KM, et al. Cyclocurcumin from Curcuma longa selectively inhibits shear stress-induced platelet aggregation. J Funct Foods. 2019;61(July):103462.
  24. Sukati S, Khobjai W. In vitro antiplatelet and anticoagulant activity of indigenous vegetables from Southern Thailand. International Journal of Applied Pharmaceutics. 2021;13(special issue 1):38–42.
  25. Miah MAS, Yeasmin T, Islam F, Yeasmin S. Antimicrobial , membrane stabilizing and thrombolytic activities of ethanolic extract of Curcuma zedoaria Rosc . Rhizome. J Pharmacogn Phytochem. 2017;6 (5)(October 2018):38–41.
  26. Hossain MS, Rahaman MM, Rahman MA, Uddin J, Ahmed F. Phytochemical and Biological Investigation of Curcuma amada Leaves. Dhaka University Journal of Pharmaceutical Sciences. 2020;19(1):9–13.
  27. Vijaya Bharathi SS, Anuradha V, Ahmad A, Tajo SM. Thrombolytic activity of curcuma amada and curcuma caesia. Asian Journal of Pharmaceutical and Clinical Research. 2017;10(2):317–8.
  28. Fathima SN, Ahmad SV, Kumar BR. Evaluation of In Vitro Thrombolytic Activity of Ethanolic Extract of CURCUMA CAESIA Rhizomes. Int J Pharma Res Rev. 2015;4(11):50–4.
  29. Vijaya Bharathi SS, Anuradha V, Ahmad A, Tajo SM. Thrombolytic activity of curcuma amada and curcuma caesia. Asian Journal of Pharmaceutical and Clinical Research. 2017 Feb 1;10(2):317–8.
  30. J D V, scholar R, Professor A. Thrombolytic activity and antimicrobial properties of SCF extract of Curcuma aeruginosa. 2019;6(2).
  31. Maduabuchi R, Kanayo P, Wilson O. Pr ep rin t n ot er re vie we d Pr ep rin t n. 2013;4(1):8–17.
  32. Fang H, Gao B, Zhao Y, Fang X, Bian M, Xia Q. Curdione inhibits thrombin-induced platelet aggregation via regulating the AMP-activated protein kinase-vinculin/talin-integrin αIIbβ3 sign pathway. Phytomedicine. 2019;61(January).
  33. Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF. Development of an in vitro model to study clot lysis activity of thrombolytic drugs. Thromb J. 2006;4:9–12.
  34. Canoa P, Simón-Vázquez R, Popplewell J, González-Fernández Á. A quantitative binding study of fibrinogen and human serum albumin to metal oxide nanoparticles by surface plasmon resonance. Biosens Bioelectron. 2015;74:376–83.
  35. Keihanian F, Saeidinia A, Bagheri RK, Johnston TP, Sahebkar A. Curcumin, hemostasis, thrombosis, and coagulation. Vol. 233, Journal of Cellular Physiology. Wiley-Liss Inc.; 2018. p. 4497–511.
  36. Dinesh Y, Abilasha R, Ramani P, Rajeshkumar S. Assessment of Cytotoxic, Antioxidant, Thrombolytic, Anti Inflammatory and Antimicrobial Activity of Curcuma longa Linn, Cissus quadrangularis and Boerhaavia diffusa Herbal Mixture - An In vitro Study. J Pharm Res Int. 2021 Dec 23;1766–77.
  37. Fang H, Gao B, Zhao Y, Fang X, Bian M, Xia Q. Curdione inhibits thrombin-induced platelet aggregation via regulating the AMP-activated protein kinase-vinculin/talin-integrin αIIbβ3 sign pathway. Phytomedicine. 2019 Aug 1;61.
  38. Zhou Y, Zhang D, Tan P, Xian B, Jiang H, Wu Q, et al. Mechanism of platelet activation and potential therapeutic effects of natural drugs. Phytomedicine. 2023 Jan 1;108.
  39. Ngo T, Kim K, Bian Y, An GJ, Bae ON, Lim KM, et al. Cyclocurcumin from Curcuma longa selectively inhibits shear stress-induced platelet aggregation. J Funct Foods. 2019 Oct 1;61.
  40. Sukati S, Khobjai W. In vitro antiplatelet and anticoagulant activity of indigenous vegetables from Southern Thailand. International Journal of Applied Pharmaceutics. 2021;13(special issue 1):38–42.
  41. Kroll KL, Amaya E. Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation. Development. 1996;122(10):3173–83.
  42. Xu XR, Carrim N, Neves MAD, McKeown T, Stratton TW, Coelho RMP, et al. Platelets and platelet adhesion molecules: Novel mechanisms of thrombosis and anti-thrombotic therapies. Thromb J. 2016;14(Suppl 1).
  43. McFadyen JD, Schaff M, Peter K. Current and future antiplatelet therapies: Emphasis on preserving haemostasis. Nat Rev Cardiol. 2018;15(3):181–91.
  44. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost. 1997;78(1):611–6.
  45. Fontana P, Zufferey A, Daali Y, Reny JL. Antiplatelet therapy: Targeting the TxA2 pathway. J Cardiovasc Transl Res. 2014 Feb;7(1):29–38.
  46. Guerrero JA, Lozano ML, Castillo J, Benavente-García O, Vicente V, Rivera J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. Journal of Thrombosis and Haemostasis. 2005;3(2):369–76.
  47. Iman RA, Priya BL, Chithra R, Shalini K, Sharon V, Chamundeeswari D, et al. In vitro Antiplatelet Activity-Guided F ractionation of Fractionation Aerial Parts of Melothria maderaspatana m o r f d a ons o l ti n a w c i do ubl e P ). e fr w m r o c f n n a l k i s e i t w s w e t s i i m o r f d a ons o l ti n a w c i o bl e Pu ). 2006;(October):5–7.
  48. Liu YL, Zhou W, Tang H Bin, Liu ZR, Liu K, Yuan LY, et al. Diffusion Coefficient of Ho3+at Liquid zinc Electrode and Co-reduction Behaviors of Ho3+ and Zn2+ on W Electrode in the LiCl-KCl Eutectic. Electrochim Acta. 2016;211:313–21.
  49. Liu Y, Oh SJ, Chang KH, Kim YG, Lee MY. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole. Biochem Pharmacol. 2013;86(7):914–25.
  50. Li Z, Delaney MK, O’Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol. 2010;30(12):2341–9.
  51. Santos-Gallego CG, Badimon J. Overview of Aspirin and Platelet Biology. American Journal of Cardiology. 2021 Apr 1;144:S2–9.
  52. Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012 Apr;45(4):221–6.
  53. Prakash P, Misra A, Surin WR, Jain M, Bhatta RS, Pal R, et al. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res. 2011;127(2):111–8.
  54. Saputri FC, Avatara C. Antithrombotic effect of Kaempferia galanga L. and Curcuma xanthorrhiza Roxb. On collagen-epinephrine induced thromboembolism in mice. Pharmacognosy Journal. 2018;10(6):1149–53.
  55. Prakash P, Misra A, Surin WR, Jain M, Bhatta RS, Pal R, et al. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res. 2011 Feb;127(2):111–8.
  56. Dohare P, Garg P, Sharma U, Jagannathan NR, Ray M. Neuroprotective efficacy and therapeutic window of curcuma oil: In rat embolic stroke model. BMC Complement Altern Med. 2008;8:1–20.
  57. Mehrotra N, Sabarinath S, Suryawanshi S, Raj K, Gupta RC. LC-UV assay for simultaneous estimation of aromatic turmerone, α/β-turmerone and curlone: Major bisabolane sesquiterpenes of turmeric oil in rabbit plasma for application to pharmacokinetic studies. Chromatographia. 2009;69(9–10):1077–82.
  58. Jayakumar T, Yang CH, Geraldine P, Yen TL, Sheu JR. The pharmacodynamics of antiplatelet compounds in thrombosis treatment. Expert Opin Drug Metab Toxicol. 2016;12(6):615–32.
  59. Huang SW, Kuo HL, Hsu MT, Tseng YJ, Lin SW, Kuo SC, et al. A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models. Thromb Haemost. 2016;116(2):285–99.
  60. Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids. 1995;52(4):223–7.
  61. Lievens D, von Hundelshausen P. Platelets in atherosclerosis. Thromb Haemost. 2011;106(5):827–38.
  62. Banerjee A, Chisti Y, Banerjee UC. Streptokinase - A clinically useful thrombolytic agent. Biotechnol Adv. 2004;22(4):287–307.
  63. Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Med.,. Planta Med. 1991;57:1–7.
  64. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: From kitchen to clinic. Biochem Pharmacol. 2008;75(4):787–809.
  65. Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food and Chemical Toxicology. 2015;83:111–24.




DOI: https://doi.org/10.18860/jim.v8i2.25929

Refbacks

  • There are currently no refbacks.


 

Editorial Office:

Faculty of Medical and Health Sciences,
Universitas Islam Negeri Maulana Malik Ibrahim
Gedung Ibnu Thufail Lt.1, Jln. Locari, Desa Tlekung, Kota Batu
Phone (+62) 85746163772, (+62) 8563588384, Faximile (+62) 341 558933
e-mail: medicaljournal@uin-malang.ac.id

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.